Get started

Fundamental Analysis

Nifty 50 Analysis Week 2 April 2022Market closed at 17894. We can see 1 Gap is pending (17990) & another Gap is below at (17389). In between that i have marked Important Support at (17754) & if this has taken out then market will try to fill the Gap which is 17389 slowly & gradually. Conditions: Market 1: If we see 17990 was taken out with huge gap-up opening then need to wait for at least 15 min, Watch out Price Action & take position accordingly. Bullish candle then Buy & If Bearish & 17990 taken out then Put Buy Simple. Market 2: If market remains flat then we have 2 options if it breaks 17990 then we can go for Buy only if OI & Volume supports Price else we can take Put entry if 17818 was taken out with small qty & if 17754 was taken out then we can do Pyramiding Simple. Market 3: If we see Major Support was taken out & sustain at least for 15 min candle then market will head towards 17555 & so on.
NSE:NIFTY1!
by Option_Kontrol
2
IDFC Ltd- A Interesting Case of UndervaluationIDFC is a Parent Company of IDFCFirst bank which holds Approx 37% Stake in IDFCFirst Bank.Currently IDFCFirst bank has a Valuation of 31000Cr. 37% will be Valued at 11000Cr. IDFC also has Mutual Fund Business with 1.26LCr AUM. Recently Listed Aditya Birla AMC has a AUM of 3.1Lakh Cr. So Market is Valuing 1LCr AUM of AMC at 6000Cr Mcap. By this Logic, IDFC AMC should be valued at 7500Cr. In Totality IDFC Business could be Valued at 18500Cr. Current Marketcap of IDFC is Just 8500Cr, A Whopping Discount to its Holding Value. Market will discover this value and bet on IDFC, If they are bullish on IDFCFirst bank.
ILong
by StrategicAlpha
Tatva Chintan Pharma- LIsting BreakoutTatva Chintan Pharma- Recent IPO - CMP 2250- Mcap 4989 Cr There is no Margin of Safety Currently in Valuations if i look it as a Long Term bet. However- Currently China Factor is Keeping Speciality Chemical Companies Afloat and Bouyant. As long as sentiments are good, Valuations can go Crazy. Speciality Chemicals can be a good Theme to Trade. Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India. The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations. Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
NSE:TATVALong
by StrategicAlpha